Cognition Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:CGTX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M Cash from investing activities -58 K-30 K——— — Cash from financing activities 329 K11.38 M1.3 M752 K33.92 M 47.35 M Free cash flow -6.85 M-8.38 M-9.88 M-5.62 M-5.65 M -29.53 M

ニュース

Cognition Therapeutics incontra la FDA per farmaco contro la demenza a corpi di Lewy

Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug

Il farmaco DLB di Cognition mostra risultati positivi in trial di fase 2

Cognition’s DLB drug shows positive results in phase 2 trial

Cognition Therapeutics completa l’arruolamento nel programma di accesso esteso

Cognition Therapeutics completes enrollment in expanded access program

Cognition Therapeutics delinea i piani di Fase 3 per farmaco contro l’Alzheimer

Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)

Cognition Therapeutics completa l’arruolamento nella sperimentazione di farmaco per l’Alzheimer

Cognition Therapeutics completes enrollment in Alzheimer’s drug trial

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?